Takeda Pharmaceutical Co Ltd: Form 20-F for the period ended Mar 31, 2023
Filed with the SEC on Jun 28, 2023 and accepted by EDGAR at Jun 28, 2023, 06:07 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-04-01 to 2023-03-31 | JPY 4.03tn | ifrs-full:Revenue |
| Cost of revenue | 12 months2022-04-01 to 2023-03-31 | JPY 1.24tn | ifrs-full:CostOfSales |
| Operating income | 12 months2022-04-01 to 2023-03-31 | JPY 490.50bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2022-04-01 to 2023-03-31 | JPY 58.05bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2022-04-01 to 2023-03-31 | JPY 317.02bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2022-04-01 to 2023-03-31 | JPY 201.94 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2022-04-01 to 2023-03-31 | JPY 204.29 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2022-04-01 to 2023-03-31 | JPY 977.16bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2022-04-01 to 2023-03-31 | JPY 140.66bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2023-03-31 | JPY 533.53bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2023-03-31 | JPY 2.40tn | ifrs-full:CurrentAssets |
| Total assets | At period end2023-03-31 | JPY 13.96tn | ifrs-full:Assets |
| Current liabilities | At period end2023-03-31 | JPY 2.48tn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2023-03-31 | JPY 7.60tn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2023-03-31 | JPY 6.35tn | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001395064-23-000072. Last ingested by Listed: Nov 5, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.